# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Merck Animal Health announced the purchase of Elanco Animal Health's aquaculture business.Merck & Company (NYSE:MRK) co...
Analysts expect Citigroup to report good earnings on Friday. Stephanie Link chose Elanco for its new products. Corning increase...
- CNBC
Piper Sandler analyst David Westenberg maintains Elanco Animal Health (NYSE:ELAN) with a Neutral and lowers the price target...
Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from...
Elanco Animal Health shares drop after updates on FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia's U.S....